---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-22-001304"
form_type: "8-K"
ticker: "EMMA"
cik: "0000822370"
company_name: "Emmaus Life Sciences, Inc."
filed_at: "2022-01-10T23:59:59+00:00"
generated_at: "2026-06-27T19:42:22.867632+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Emmaus Life Sciences appoints Lori Teranishi as director

## Summary
- Board expanded from 7 to 8 on Jan 6, 2022; Teranishi appointed.
- Teranishi is founder & CEO of iQ 360, a strategic communications firm.
- She will receive standard non-employee director compensation per proxy.
- Expected to join board committees when schedule allows.
- No family relationships or related-party transactions disclosed.

## SEC filing metadata
- accession: 0001213900-22-001304
- form_type: 8-K
- ticker: EMMA
- cik: 0000822370
- company_name: Emmaus Life Sciences, Inc.
- filed_at: 2022-01-10T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/822370/000121390022001304/0001213900-22-001304-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/822370/000121390022001304/ea153776-8k_emmauslife.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-22-001304
- JSON: https://secwatch.observer/filing/0001213900-22-001304.json
- Plain text: https://secwatch.observer/filing/0001213900-22-001304.txt

## Key facts
- Executive change
  Lori Teranishi was appointed as director at Emmaus Life Sciences, Inc..
  - Action: appointed
  - Role: director
  source text: expanded the number of directors from seven to eight and appointed Lori Teranishi as a director of the company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/822370/000121390022001304/0001213900-22-001304-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.